Researchers are excited about the medication , a innovative dual agonist showing remarkable results in clinical trials for size reduction . It works by targeting both hormones : GLP-1 and GIP, which , https://jessexsfw711734.blogadvize.com/49231745/a-new-prospect-for-body-management